Citigroup Inc Pa Vmed Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.85 - $1.41 $238 - $394	-280 Reduced 3.71%	7,277 $7,000
Q1 2022 May 12, 2022	SELL	$1.16 - $2.5 $12,313 - $26,537	-10,615 Reduced 58.41%	7,557 $10,000
Q4 2021 Feb 10, 2022	BUY	$2.46 - $8.74 $25,055 - $89,016	10,185 Added 127.52%	18,172 $45,000
Q3 2021 Nov 10, 2021	BUY	$5.1 - $9.39 $40,733 - $74,997	7,987 New	7,987 $68,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.